Dennis J. Carlo
2017
In 2017, Dennis J. Carlo earned a total compensation of $2.6M as President and Chief Executive Officer at Adamis Pharmaceuticals, a 45% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,825 |
|---|---|
| Option Awards | $834,750 |
| Salary | $605,000 |
| Stock Awards | $875,000 |
| Other | $27,189 |
| Total | $2,562,764 |
Carlo received $875K in stock awards, accounting for 34% of the total pay in 2017.
Carlo also received $220.8K in non-equity incentive plan, $834.8K in option awards, $605K in salary and $27.2K in other compensation.
Rankings
In 2017, Dennis J. Carlo's compensation ranked 4,324th out of 14,666 executives tracked by ExecPay. In other words, Carlo earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,324 out of 14,666 | 71st |
Division Manufacturing | 1,517 out of 5,768 | 74th |
Major group Chemicals And Allied Products | 438 out of 2,074 | 79th |
Industry group Drugs | 335 out of 1,730 | 81st |
Industry Pharmaceutical Preparations | 265 out of 1,329 | 80th |
Source: SEC filing on June 7, 2018.
Carlo's colleagues
We found two more compensation records of executives who worked with Dennis J. Carlo at Adamis Pharmaceuticals in 2017.